Premiums for public U.S. biopharma company trade sales 2010-2019
In 2019, the average premiums paid in public takeovers in the U.S. biopharma industry reached 97 percent, a significant increase from the 73 percent premiums paid the previous year. This statistic shows the average premiums paid in public U.S. biopharma company M&A deals from 2010 to 2019.
